a month ago
LLY
AnalystsCarter GouldCarter Gould's Stock Forecasts
AnalystsCarter Gould
Analyst Ranking
Top 19%
#810 out of 4333 analysts
Average Return
+3.59%
Win Rate
47%35 out of 74
Risk vs Reward
Poor
Good
Carter Gould's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-09 - 2023-08-01 | Strong Buy |
Reata Pharmaceuticals IncRETA | +88.73% | $88.01 | $166.10 | 2023-05-11 - 2023-08-01 | Strong Buy |
Reata Pharmaceuticals IncRETA | +78.28% | $93.17 | $166.10 | 2023-03-01 - 2023-08-01 | Strong Buy |
Reata Pharmaceuticals IncRETA | +68.07% | $98.83 | $166.10 | 2023-06-28 - 2023-08-01 | Strong Buy |
Eli Lilly & CoLLY | +60.48% | $354.96 | $569.64 | 2022-11-02 - 2023-09-20 | Strong Buy |
Carter Gould Analyst Color
Get additional color on Carter Gould's coverage of popular stocks
2 months ago
PFE
5 months ago
PFE
5 months ago
LLY
5 months ago
PFE
8 months ago
PFE
a year ago
PFE
a year ago
LLY
a year ago
PFE
a year ago
ABBV
a year ago
ABBV
2 years ago
PFE
Carter Gould's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 9 | Strong Buy | $925.00 | +11.23% | Maintains | a month ago |
Skillsoft CorpSKIL | 3 | Strong Buy | $2.50 | +142.72% | Maintains | a month ago |
Eli Lilly & CoLLY | 7 | Strong Buy | $590.00 | +3.57% | Maintains | a month ago |
Biogen IncBIIB | 17 | Hold | $294.00 | +12.85% | Maintains | a month ago |
Reata Pharmaceuticals IncRETA | 7 | Hold | $172.00 | -0.12% | Downgrades | 2 months ago |
Bristol Myers Squibb CoBMY | 8 | Hold | $62.00 | +5.48% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 8 | Hold | $80.00 | +5.51% | Maintains | 2 months ago |
Pfizer IncPFE | 9 | Hold | $38.00 | +13.03% | Maintains | 2 months ago |
Amgen IncAMGN | 12 | Strong Sell | $210.00 | -22.64% | Maintains | 2 months ago |
Arcellx IncACLX | 2 | Strong Buy | $49.00 | +41.99% | Maintains | 4 months ago |
Alector IncALEC | 2 | Strong Buy | $12.00 | +97.69% | Maintains | 5 months ago |
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $125.00 | +9.28% | Maintains | 5 months ago |
Merck & Co IncMRK | 6 | Strong Buy | $130.00 | +21.14% | Maintains | 5 months ago |
Gossamer Bio IncGOSS | 5 | Hold | $1.50 | +68.92% | Maintains | 6 months ago |
Travere Therapeutics IncTVTX | 2 | Strong Buy | $31.00 | +140.68% | Maintains | 7 months ago |
Vor Biopharma IncVOR | 2 | Strong Buy | $15.00 | +578.73% | Maintains | 10 months ago |
Molecular Templates IncMTEM | 3 | Strong Buy | $15.00 | +121.08% | Maintains | 10 months ago |
Abbvie IncABBV | 6 | Hold | $155.00 | +0.90% | Maintains | a year ago |
Applied Therapeutics IncAPLT | 4 | Hold | $2.25 | N/A | Maintains | a year ago |
Allakos IncALLK | 2 | Strong Sell | $2.50 | N/A | Maintains | a year ago |
Paycom Software IncPAYC | 1 | Hold | $380.00 | N/A | Maintains | 2 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | 2 years ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Celgene CorpCELG | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Incyte CorpINCY | 3 | Hold | $82.00 | N/A | Downgrades | 5 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Hold | $188.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.